A novel, high-density CRISPR activation platform for mapping cancer dependencies and resistance pathways <i>ex vivo</i> and <i>in vivo</i>
Sarah T. Diepstraten(IHI Corporation (United States)), Marco J. Herold(The University of Melbourne)
Cited by 1
Related Papers
Glucocorticoids in T cell apoptosis and function
|Cellular and Molecular Life Sciences|2005|390
Flexible Usage and Interconnectivity of Diverse Cell Death Pathways Protect against Intracellular Infection
|Immunity|2020|148
Generation of a CRISPR activation mouse that enables modelling of aggressive lymphoma and interrogation of venetoclax resistance
|Nature Communications|2022|23
Genome-wide <i>in vivo</i> CRISPR screens identify GATOR1 as a potent tumor suppressor in MYC-driven lymphomagenesis
|bioRxiv (Cold Spring Harbor Laboratory)|2022|3
Genome-wide in vivo CRISPR screens identify GATOR1 complex as a tumor suppressor in Myc-driven lymphoma
|Nature Communications|2025|2